Literature DB >> 19374899

Alpha-lipoic acid and frataxin: a new indication for an old antioxidant?

James W Russell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19374899      PMCID： PMC2772894          DOI： 10.1016/j.expneurol.2009.04.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  13 in total

Review 1.  Autophagy in health and disease: a double-edged sword.

Authors:  Takahiro Shintani; Daniel J Klionsky
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

Review 2.  Interventions for preventing neuropathy caused by cisplatin and related compounds.

Authors:  J Albers; V Chaudhry; G Cavaletti; R Donehower
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Aerobic metabolism underlies complexity and capacity.

Authors:  Lauren G Koch; Steven L Britton
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

4.  Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.

Authors:  Giorgia Melli; Michela Taiana; Francesca Camozzi; Daniela Triolo; Paola Podini; Angelo Quattrini; Franco Taroni; Giuseppe Lauria
Journal:  Exp Neurol       Date:  2008-09-09       Impact factor: 5.330

5.  Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

Authors:  D Strumberg; S Brügge; M W Korn; S Koeppen; J Ranft; G Scheiber; C Reiners; C Möckel; S Seeber; M E Scheulen
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

6.  Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.

Authors:  Elizabeth S McDonald; Kelli R Randon; Andrew Knight; Anthony J Windebank
Journal:  Neurobiol Dis       Date:  2005-03       Impact factor: 5.996

Review 7.  Advances in understanding drug-induced neuropathies.

Authors:  Amanda C Peltier; James W Russell
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

Authors:  D Ziegler; M Hanefeld; K J Ruhnau; H Hasche; M Lobisch; K Schütte; G Kerum; R Malessa
Journal:  Diabetes Care       Date:  1999-08       Impact factor: 19.112

9.  Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.

Authors:  Valentina Carozzi; Alessia Chiorazzi; Annalisa Canta; Norberto Oggioni; Alessandra Gilardini; Virginia Rodriguez-Menendez; Federica Avezza; Luca Crippa; Cecilia Ceresa; Gabriella Nicolini; Mario Bossi; Guido Cavaletti
Journal:  Eur J Cancer       Date:  2008-12-16       Impact factor: 9.162

10.  Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia.

Authors:  Alessandro Campanella; Elisabetta Rovelli; Paolo Santambrogio; Anna Cozzi; Franco Taroni; Sonia Levi
Journal:  Hum Mol Genet       Date:  2008-09-24       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.